Model predictive control of ultrasound hyperthermia treatments of cancer

A model predictive controller (MPC) of the thermal dose in hyperthermia cancer treatments has been developed and evaluated using simulations with one-point and one-dimensional models of a tumor. The developed controller is the first effort in (a) the application of feedback control to pulsed, high temperature hyperthermia treatments, (b) the direct control of the treatment thermal dose rather than the treatment temperatures, and (c) the application of MPC to hyperthermia treatments. Simulations were performed with different blood flow rates in the tumor and constraints on temperatures in normal tissues. The results demonstrate that (a) thermal dose can be controlled in the presence of plant-model mismatch, (b) constraints on the maximum allowable temperatures in normal tissue and/or the pulsed power magnitude can be directly incorporated into MPC and met while delivering the desired thermal dose to the tumor.

[1]  R B Roemer,et al.  Obtaining local SAR and blood perfusion data from temperature measurements: steady state and transient techniques compared. , 1985, International journal of radiation oncology, biology, physics.

[2]  A. Hart,et al.  Comparison of radiotherapy alone with radiotherapy plus hyperthermia in locally advanced pelvic tumours: a prospective, randomised, multicentre trial , 2000, The Lancet.

[3]  W. Dewey,et al.  Thermal dose determination in cancer therapy. , 1984, International journal of radiation oncology, biology, physics.

[4]  N. Marceau,et al.  Rate-limiting events in hyperthermic cell killing. , 1978, Radiation research.

[5]  R B Roemer,et al.  Engineering aspects of hyperthermia therapy. , 1999, Annual review of biomedical engineering.

[6]  M Knudsen,et al.  Two-point control of temperature profile in tissue. , 1986, International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group.

[7]  K Hynynen,et al.  The feasibility of MRI feedback control for intracavitary phased array hyperthermia treatments. , 1998, International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group.

[8]  K. Hynynen Biophysics and Technology of Ultrasound Hyperthermia , 1990 .

[9]  S L George,et al.  Cumulative minutes with T90 greater than Tempindex is predictive of response of superficial malignancies to hyperthermia and radiation. , 1993, International journal of radiation oncology, biology, physics.

[10]  J. Overgaard,et al.  Randomised trial of hyperthermia as adjuvant to radiotherapy for recurrent or metastatic malignant melanoma , 1995, The Lancet.

[11]  E. Moros,et al.  Numerical and in vitro evaluation of temperature fluctuations during reflected-scanned planar ultrasound hyperthermia. , 1998, International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group.

[12]  P. VanBaren,et al.  Multipoint temperature control during hyperthermia treatments: theory and simulation , 1995, IEEE Transactions on Biomedical Engineering.

[13]  R B Roemer,et al.  Effects of physical parameters on high temperature ultrasound hyperthermia. , 1990, Ultrasound in medicine & biology.

[14]  W. Dewey,et al.  Time-temperature analysis of cell killing of BHK cells heated at temperatures in the range of 43.5°C to 57.0°C☆ , 1990 .